Last 12 months
Inside the activity.
0 purchase rows · 75 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 11 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 8 |
| Mar 2026 | 0 | 3 |
| Apr 2026 | 0 | 4 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 7 |
| Jul 2026 | 0 | 4 |
| Aug 2026 | 0 | 15 |
| Sep 2026 | 0 | 7 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 27, 2026 Filed Mar 2, 2026 21:54 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
GrantCommon Stock | 11,090 | $0.00 | $0.00 |
DisclosureSEC source: 0001782135-26-000008 · wk-form4_1772488451.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 131,378 F1 · kind: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. Read SEC document |
| February 27, 2026 Filed Mar 2, 2026 21:48 UTC |
Cain Wettan Keeley MEVP Gen Counsel, Legal & Comp
|
GrantCommon Stock | 470 | $0.00 | $0.00 |
DisclosureSEC source: 0002110603-26-000004 · wk-form4_1772488110.xml · nonDerivative · entry 1 Cain Wettan Keeley M · CIK 0002110603 · EVP Gen Counsel, Legal & Comp 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,414 F1 · acquired: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2025. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 22:11 UTC |
Dickinson Andrew DChief Financial Officer
|
SaleCommon Stock | 3,000 | $154.43 | $463,290.00 |
DisclosureSEC source: 0001310204-26-000006 · wk-form4_1771452697.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 167,779 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. F2 · balance_after: Balance adjusted to reflect shares acquired under the Gilead Sciences, Inc. Employee Stock Purchase Plan. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 22:22 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $66.64 | $0.00 |
DisclosureSEC source: 0001782135-26-000006 · wk-form4_1771453372.xml · derivative · entry 5 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 48,110 Underlying: Common Stock · 25,000 shares Expires 2029-07-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F4 · derivative.exercise_date: The options have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 22:22 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
SaleCommon Stock | 200 | $155.62 | $31,124.00 |
DisclosureSEC source: 0001782135-26-000006 · wk-form4_1771453372.xml · nonDerivative · entry 4 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,288 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 22:22 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
SaleCommon Stock | 9,395 | $154.91 | $1,455,384.15 |
DisclosureSEC source: 0001782135-26-000006 · wk-form4_1771453372.xml · nonDerivative · entry 3 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 120,488 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F3 · price: Sale prices for the transactions reported range from $154.57 to $155.27 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 22:22 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
SaleCommon Stock | 18,405 | $154.18 | $2,837,719.71 |
DisclosureSEC source: 0001782135-26-000006 · wk-form4_1771453372.xml · nonDerivative · entry 2 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 129,883 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. F2 · price: Sale prices for the transactions reported range from $153.565 to $154.56 Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Read SEC document |
| February 17, 2026 Filed Feb 18, 2026 22:22 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
Exercise / conversionCommon Stock | 25,000 | $66.64 | $1,666,000.00 |
DisclosureSEC source: 0001782135-26-000006 · wk-form4_1771453372.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 148,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:22 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 115,640 | $0.00 Strike: $66.01 | $0.00 |
DisclosureSEC source: 0001638643-26-000010 · wk-form4_1770412954.xml · derivative · entry 3 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 115,640 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F2 · derivative.exercise_date: The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:22 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
SaleCommon Stock | 115,640 | $150.00 | $17,346,000.00 |
DisclosureSEC source: 0001638643-26-000010 · wk-form4_1770412954.xml · nonDerivative · entry 2 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 613,912 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. Read SEC document |
| February 05, 2026 Filed Feb 6, 2026 21:22 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 115,640 | $66.01 | $7,633,396.40 |
DisclosureSEC source: 0001638643-26-000010 · wk-form4_1770412954.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 729,552 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 23:49 UTC |
Dickinson Andrew DChief Financial Officer
|
Tax withholdingCommon Stock | 24,802 | $143.28 | $3,553,630.56 |
DisclosureSEC source: 0001310204-26-000004 · wk-form4_1770335396.xml · nonDerivative · entry 2 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 170,568 Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 23:49 UTC |
Dickinson Andrew DChief Financial Officer
|
GrantCommon Stock | 44,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001310204-26-000004 · wk-form4_1770335396.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 195,370 F1 · acquired: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 23:46 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 74,461 | $143.28 | $10,668,772.08 |
DisclosureSEC source: 0001638643-26-000008 · wk-form4_1770335197.xml · nonDerivative · entry 2 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 613,912 Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 23:46 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
GrantCommon Stock | 131,675 | $0.00 | $0.00 |
DisclosureSEC source: 0001638643-26-000008 · wk-form4_1770335197.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 688,373 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 23:51 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
Tax withholdingCommon Stock | 24,800 | $143.28 | $3,553,344.00 |
DisclosureSEC source: 0001782135-26-000004 · wk-form4_1770335486.xml · nonDerivative · entry 2 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 123,288 Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 23:51 UTC |
Mercier JohannaChief Comm & Corp Aff Officer
|
GrantCommon Stock | 44,867 | $0.00 | $0.00 |
DisclosureSEC source: 0001782135-26-000004 · wk-form4_1770335486.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Comm & Corp Aff Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 148,088 F1 · shares: Represents shares of the Issuer's common stock subject to specific tranches of the performance share awards made to the Reporting Person on March 10, 2023 and March 10, 2024. Such tranches of shares were subject to both performance-vesting and service-vesting requirements. The performance vesting requirement was satisfied on the date reported in Column 2 above upon certification of performance goal attainment by the Compensation and Talent Committee of the Issuer's Board of Directors. However, the shares certified for grants made March 10, 2024 will not be issued to the Reporting Person until the requisite continuing service requirements are also met. Read SEC document |
| January 28, 2026 Filed Jan 29, 2026 22:23 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
SaleCommon Stock | 4,968 | $140.24 | $696,725.24 |
DisclosureSEC source: 0001638643-26-000006 · wk-form4_1769725380.xml · nonDerivative · entry 2 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 556,698 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F3 · price: Sale prices for the transactions reported range from $140.00 to $140.57. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Read SEC document |
| January 28, 2026 Filed Jan 29, 2026 22:23 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
SaleCommon Stock | 5,032 | $139.54 | $702,185.91 |
DisclosureSEC source: 0001638643-26-000006 · wk-form4_1769725380.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 561,666 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F2 · price: Sale prices for the transactions reported range from $138.99 to $139.97. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 00:29 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 115,640 | $0.00 Strike: $66.01 | $0.00 |
DisclosureSEC source: 0001638643-26-000004 · wk-form4_1769473761.xml · derivative · entry 3 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 115,640 Underlying: Common Stock · 115,640 shares Expires 2029-03-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F2 · derivative.exercise_date: The stock options have a four-year vesting schedule. 25% of the stock options vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 00:29 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
SaleCommon Stock | 115,640 | $135.00 | $15,611,400.00 |
DisclosureSEC source: 0001638643-26-000004 · wk-form4_1769473761.xml · nonDerivative · entry 2 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 566,698 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 00:29 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 115,640 | $66.01 | $7,633,396.40 |
DisclosureSEC source: 0001638643-26-000004 · wk-form4_1769473761.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 682,338 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:26 UTC |
Bluestone JeffreyDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $67.45 | $0.00 |
DisclosureSEC source: 0001771814-26-000002 · wk-form4_1769030768.xml · derivative · entry 3 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,665 Underlying: Common Stock · 5,000 shares Expires 2031-05-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025. F2 · derivative.exercise_date: 25% of the shares subject to the option vest on each three-month anniversary from May 12, 2021 such that 100% of the shares subject to the option will be fully vested and exercisable upon the earlier of May 12, 2022 or the day immediately preceding the next regular annual stockholders meeting. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:26 UTC |
Bluestone JeffreyDirector
|
SaleCommon Stock | 5,000 | $123.50 | $617,500.00 |
DisclosureSEC source: 0001771814-26-000002 · wk-form4_1769030768.xml · nonDerivative · entry 2 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 8,920 F1 · kind: The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025. Read SEC document |
| January 20, 2026 Filed Jan 21, 2026 21:26 UTC |
Bluestone JeffreyDirector
|
Exercise / conversionCommon Stock | 5,000 | $67.45 | $337,250.00 |
DisclosureSEC source: 0001771814-26-000002 · wk-form4_1769030768.xml · nonDerivative · entry 1 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transactions reported on this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 13, 2025. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 23:18 UTC |
Dickinson Andrew DChief Financial Officer
|
SaleCommon Stock | 3,000 | $124.31 | $372,930.00 |
DisclosureSEC source: 0001310204-26-000002 · wk-form4_1768605499.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 150,503 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 23:10 UTC |
Mercier JohannaChief Commercial Officer
|
SaleCommon Stock | 3,000 | $124.31 | $372,930.00 |
DisclosureSEC source: 0001782135-26-000002 · wk-form4_1768605033.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 103,221 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:56 UTC |
Berger DietmarChief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 16,326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001739515-26-000002 · wk-form4_1767653790.xml · derivative · entry 3 Berger Dietmar · CIK 0001739515 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,179 Underlying: Common Stock · 16,326 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested. F2 · derivative.expiration_date: The restricted stock units vest in approximately three equal installments on the first three anniversaries of the date of grant until fully vested. Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:56 UTC |
Berger DietmarChief Medical Officer
|
Tax withholdingCommon Stock | 6,944 | $121.60 | $844,390.40 |
DisclosureSEC source: 0001739515-26-000002 · wk-form4_1767653790.xml · nonDerivative · entry 2 Berger Dietmar · CIK 0001739515 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,382 Read SEC document |
| January 02, 2026 Filed Jan 5, 2026 22:56 UTC |
Berger DietmarChief Medical Officer
|
Exercise / conversionCommon Stock | 16,326 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001739515-26-000002 · wk-form4_1767653790.xml · nonDerivative · entry 1 Berger Dietmar · CIK 0001739515 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,326 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 21:23 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
SaleCommon Stock | 10,000 | $124.83 | $1,248,272.00 |
DisclosureSEC source: 0001638643-25-000017 · wk-form4_1767129779.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 566,698 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F2 · price: Sale prices for the transactions reported range from $124.40 to $125.16. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 23:31 UTC |
Dickinson Andrew DChief Financial Officer
|
SaleCommon Stock | 3,000 | $122.00 | $366,000.00 |
DisclosureSEC source: 0001310204-25-000021 · wk-form4_1765927916.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,503 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 29, 2024. Read SEC document |
| December 15, 2025 Filed Dec 16, 2025 23:12 UTC |
Mercier JohannaChief Commercial Officer
|
SaleCommon Stock | 3,000 | $122.00 | $366,000.00 |
DisclosureSEC source: 0001782135-25-000017 · wk-form4_1765926757.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,221 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on February 20, 2025. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 01:40 UTC |
Dickinson Andrew DChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,693 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001310204-25-000019 · wk-form4_1765503597.xml · derivative · entry 3 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,526 Underlying: Common Stock · 3,693 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 01:40 UTC |
Dickinson Andrew DChief Financial Officer
|
Tax withholdingCommon Stock | 1,745 | $121.34 | $211,738.30 |
DisclosureSEC source: 0001310204-25-000019 · wk-form4_1765503597.xml · nonDerivative · entry 2 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,503 Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 01:40 UTC |
Dickinson Andrew DChief Financial Officer
|
Exercise / conversionCommon Stock | 3,693 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001310204-25-000019 · wk-form4_1765503597.xml · nonDerivative · entry 1 Dickinson Andrew D · CIK 0001310204 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 01:38 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Exercise / conversionRestricted Stock Unit · Derivative | 10,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001638643-25-000015 · wk-form4_1765503524.xml · derivative · entry 3 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,070 Underlying: Common Stock · 10,426 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 01:38 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Tax withholdingCommon Stock | 4,931 | $121.34 | $598,327.54 |
DisclosureSEC source: 0001638643-25-000015 · wk-form4_1765503524.xml · nonDerivative · entry 2 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 576,698 Read SEC document |
| December 10, 2025 Filed Dec 12, 2025 01:38 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
Exercise / conversionCommon Stock | 10,426 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001638643-25-000015 · wk-form4_1765503524.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 581,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:25 UTC |
Mercier JohannaChief Commercial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 3,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001782135-25-000015 · wk-form4_1765495531.xml · derivative · entry 3 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,674 Underlying: Common Stock · 3,842 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. F2 · derivative.exercise_date: The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. F2 · derivative.expiration_date: The restricted stock units have a four-year vesting schedule. 25% vest on the first anniversary of the date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:25 UTC |
Mercier JohannaChief Commercial Officer
|
Tax withholdingCommon Stock | 1,814 | $121.34 | $220,110.76 |
DisclosureSEC source: 0001782135-25-000015 · wk-form4_1765495531.xml · nonDerivative · entry 2 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 109,221 Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 23:25 UTC |
Mercier JohannaChief Commercial Officer
|
Exercise / conversionCommon Stock | 3,842 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001782135-25-000015 · wk-form4_1765495531.xml · nonDerivative · entry 1 Mercier Johanna · CIK 0001782135 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,035 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:54 UTC |
Kramer Kelly A.Director
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 2,805 | $0.00 Strike: $81.00 | $0.00 |
DisclosureSEC source: 0001629885-25-000005 · wk-form4_1764626091.xml · derivative · entry 6 Kramer Kelly A. · CIK 0001629885 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,805 shares Expires 2026-08-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025. F2 · derivative.exercise_date: Options vest quarterly over the first year of service and were fully vested on August 19, 2017. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:54 UTC |
Kramer Kelly A.Director
|
SaleCommon Stock | 2,805 | $127.10 | $356,515.50 |
DisclosureSEC source: 0001629885-25-000005 · wk-form4_1764626091.xml · nonDerivative · entry 4 Kramer Kelly A. · CIK 0001629885 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,339 F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:54 UTC |
Kramer Kelly A.Director
|
Exercise / conversionCommon Stock | 2,805 | $81.00 | $227,205.00 |
DisclosureSEC source: 0001629885-25-000005 · wk-form4_1764626091.xml · nonDerivative · entry 3 Kramer Kelly A. · CIK 0001629885 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The transaction reported in this Form 4 is made pursuant to a Rule 10b5-1 trading plan adopted on August 27, 2025. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:50 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
SaleCommon Stock | 6,788 | $126.84 | $861,015.71 |
DisclosureSEC source: 0001638643-25-000013 · wk-form4_1764625837.xml · nonDerivative · entry 2 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 571,203 F1 · kind: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F3 · price: Sale prices for the transactions reported range from $126.50 to $127.48. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 21:50 UTC |
O'Day Daniel PatrickDirector · Chairman & CEO
|
SaleCommon Stock | 3,212 | $125.91 | $404,428.06 |
DisclosureSEC source: 0001638643-25-000013 · wk-form4_1764625837.xml · nonDerivative · entry 1 O'Day Daniel Patrick · CIK 0001638643 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 577,991 F1 · kind: The transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan adopted on February 28, 2025. F2 · price: Sale prices for the transactions reported range from $125.41 to $126.33. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer, or its shareowners upon request. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 23:11 UTC |
Bluestone JeffreyDirector
|
Exercise / conversionNon-qualified Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $64.92 | $0.00 |
DisclosureSEC source: 0001771814-25-000005 · wk-form4_1764630716.xml · derivative · entry 3 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,648 Underlying: Common Stock · 5,000 shares Expires 2034-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: 100% of the shares subject to the stock option vested immediately upon the grant date of May 8, 2024. Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 23:11 UTC |
Bluestone JeffreyDirector
|
SaleCommon Stock | 5,000 | $125.08 | $625,400.00 |
DisclosureSEC source: 0001771814-25-000005 · wk-form4_1764630716.xml · nonDerivative · entry 2 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,920 Read SEC document |
| November 28, 2025 Filed Dec 1, 2025 23:11 UTC |
Bluestone JeffreyDirector
|
Exercise / conversionCommon Stock | 5,000 | $64.92 | $324,600.00 |
DisclosureSEC source: 0001771814-25-000005 · wk-form4_1764630716.xml · nonDerivative · entry 1 Bluestone Jeffrey · CIK 0001771814 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,920 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.